Search bioRxiv⌕ Search

Biology subjects

DALOD, M.

Publications and source records attributed to DALOD, M..

5 recordsLinked to original sources

In vitro-generated murine monocyte-derived dendritic cells habor a unique identity compared to other mononuclear phagocytes, largely conserved with their human and putative in vivo counterparts.

Whether the cells differentiating in vitro from total murine bone marrow (BM) cultures with GM-CSF +/- IL-4 are homologous to the human cells derived in vitro from purified circulating monocytes (Mo) cultured with GM-CSF and IL-4, mostly correspond to monocyte-derived dendritic cells (moDCs) or rather to macrophages (MFs), and have in vivo counterparts, is debated. It has been proposed to define cell types based on their ontogeny, leading to the proposal of excluding from the dendritic cell (DC) family the cells that do not arise from the common DC progenitors (CDP). However, recent discoveries support defining cell types rather by functions, or, as a surrogate, their instructive molecular networks. Indeed, Langerhans cells, Rorgt+ DCs, some cDC2As and human in vitro-derived moDCs do not arise from the CDP but exert hallmark DC functions instructed by specific transcriptomic modules shared with cDCs. Actually, the study of both LCs and moDCs has been key for dissecting DC biology. Yet, the existence of moDCs is put into questions. The functions once attributed to moDCs are now proposed to be exerted by type 2B conventional DCs (cDC2Bs) or type 3 DCs (DC3s) that have been characterized recently, harbor strongly overlapping phenotypes with moDCs and a similar mixed expression of genes from both the cDC and Mo/MF lineages, but a different ontogeny. To clarify these issues, we generated a transcriptomic atlas of in vitro-derived mononuclear phagocytes (MNPs). We show that moDCs are the only DC type arising in BM cultures in the presence of GM-CSF and IL-4. They express a unique transcriptomic and phenotypic signature, different from those of cDC2Bs and DC3s that are produced in FLT3-L cultures and appear to correspond to the same DC type differentiating though two different but converging ontogenetic paths. By harnessing the phenotypic and transcriptomic signatures identified from the analysis of our in vitro MNP atlas, we are able to identify in vivo a population of putative DCs differentiated from monocytes derived from the common monocyte-granulocyte progenitor (GMP), in a respiratory allergy model, specifically in the lungs of mice sensitized to house dust mite (HDM). Using the model of thioglycolate-induced peritonitis, we also characterized the CD226+ Mo-derived cells that have been reported to be moDCs or small cavity MFs (SCM) depending on studies. We showed that these cells are mainly differentiated from monocytes derived from the MDP, and split into two populations, one resembling MFs (SCMs) and the other one closer to lung moDCs but expressing distinct genes suggesting a different functional potential. Collectively, we show that the generation and characterization of specific MNP types in vitro can be harnessed to rigorously define their in vivo counterparts based on phenotypic analysis and gene module assessment, as we demonstrate for moDCs.

immunology↗

Mast cells are not essential for pubertal mammary gland branching.

Mast cells are long-lived, tissue-resident immune cells of the myeloid lineage with cardinal functions in allergy and atopic disease. They are now increasingly recognized also for protective roles e.g. against infections and venoms. Other functions originally assigned to mast cells in development and physiology, however, have been refuted, and for yet others, their true contribution remains uncertain. Mast cells have been implicated in promoting ductal branching in the pubertal mammary gland, the organ that produces and secretes milk in mammals, but these findings are based on mouse models that are not mast cell-specific. In this study, we therefore re-addressed the impact of mast cells on mammary gland branching using several complementary genetic models, including a new transgenic line. We report that neither constitutive deficiency of mast cells, nor their conditional ablation induced at puberty affected mammary gland branching. Our results thus dispute that mast cells promote this process in mice, at least in a unique and non-redundant manner. This study adds to a growing body of work clarifying the biological roles of mast cells, and further expands the toolbox available to the field of mast cell research.

developmental biology↗

Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections

Plasmacytoid dendritic cells (pDCs) are major producers of type I/III interferons. As interferons are crucial for antiviral defense, pDCs are assumed to play an essential role in this process. However, robust evidence supporting this dogma is scarce. Genetic or pharmacological manipulations that eliminate pDC or disrupt their interferon production often affect other cells, confounding interpretation. To overcome this issue, we engineered pDC-less mice that are specifically and constitutively devoid of pDCs by expressing diphtheria toxin under coordinated control of the Siglech and Pacsin1 genes, uniquely co-expressed in pDCs. pDC-less mice mounted protective immunity against systemic infection with mouse Cytomegalovirus and showed higher survival and less lung immunopathology to intranasal infection with influenza virus and SARS-CoV2. Thus, contrary to the prevailing dogma, we revealed that pDCs and their interferons are dispensable or deleterious during several viral infections. pDC-less mice will enable rigorously reassessing the roles of pDCs in health and disease.

immunology↗

DCs targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors

Cross-presentation by type 1 cDCs (cDC1) is critical to induce and sustain antitumoral CD8 T cell responses to model antigens, in various tumor settings. However, the impact of cross-presenting cDC1 and the potential of DC-based therapies in tumors carrying varied levels of bona-fide neoantigens (neoAgs) remains unclear. Here we generated a non-small cell lung cancer model with distinct ranges of TMB and MHC-I neoepitopes to test immunogenicity and response to Flt3L+CD40 (DC-therapy). We found that cDC1 are required to broaden the pattern of CD8 responses to basal and acquired neoAgs and DC-therapy strongly inhibits the growth of TMBhigh tumors. In contrast, TMBlow tumors induce weaker responses that are not sufficient to block progression. scRNA transcriptional analysis, immune profiling and functional assays show that DC-therapy triggers the accumulation of lung cDC1 with increased immunostimulatory properties and CD8 T cells with enhanced cytotoxic functions and reduced exhaustion, most prominently in neoAgshigh tumors. We conclude that boosting cDC1 activity is critical to broaden the diversity of anti-tumoral CD8 T cell responses and to leverage neoAgs content for therapeutic advantage.

immunology↗

A gene silencing pipeline to interrogate human cDC1 and pDC development and functions

Type 1 conventional dendritic cells (cDC1s) and plasmacytoid dendritic cells (pDCs) are thought to be critical for anti-tumor or antiviral immunity. In vitro differentiation systems have unlocked the ability to produce large numbers of these cells. However, a method is lacking to systematically identify the cell-intrinsic factors controlling their differentiation and functions that remain therefore poorly understood, in contrast to the situation in mice. Here, we developed a workflow for efficient gene silencing and its tracing in human cDC1s/pDCs generated in vitro. As proof of concept, we confirmed the key role of IRF8 in their development, and of IRF7/MyD88 in human pDC production of interferons-/{lambda}. We found that SAMHD1 and RAB7B promote human cDC1 differentiation, while SEPT3 promotes human pDC differentiation. We also found that PPT1 and RAB5 are required for optimal differentiation of pDCs and cDC1s. Finally, we identified BCL11A, PPT1 and RAB7 as novel HIV-1 restriction factors in cDC1s/pDCs. This approach will enable broader genetic screens to advance our understanding of human cDC1s/pDCs and harness them against viral infections or cancer.

immunology↗